Literature DB >> 10886208

Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.

E Haralambieva1, K A Pulford, L Lamant, S Pileri, G Roncador, K C Gatter, G Delsol, D Y Mason.   

Abstract

There is controversy in the literature as to whether anaplastic large-cell lymphoma of B-cell phenotype is related to the t(2;5)-positive T- or 'null' cell lymphoma of the same morphology. We report a study of 24 lymphomas with morphological features of anaplastic large-cell lymphoma which expressed one or more B-cell markers and lacked T-lineage markers. Clinical features were more in keeping with large B-cell lymphoma than with classical t(2;5)-positive anaplastic large-cell lymphoma, and immunostaining for anaplastic lymphoma kinase (ALK) protein provided no evidence for the (2;5) translocation (or one of its variants). The staining patterns for CD20 and CD79 were typical of diffuse large B-cell lymphoma, CD30 expression was variable, and most cases (15/22) lacked epithelial membrane antigen (EMA). These findings support the view that 'B-cell anaplastic large-cell lymphoma' is unrelated to t(2;5)-positive (ALK-positive) lymphoma, and that it represents a morphological pattern occasionally encountered among diffuse large B-cell lymphomas. By the same reasoning, most tumours diagnosed as 'ALK-negative anaplastic large-cell lymphoma of T-cell or null phenotype' probably belong to the spectrum of peripheral T-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886208     DOI: 10.1046/j.1365-2141.2000.02045.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Primary mediastinal anaplastic alk-1-positive large-cell lymphoma of T/NK-cell type expressing CD20.

Authors:  J Gonin; H Kadiri; S Bensaci; A Le Tourneau; T J Molina; J Diebold; D J Abdellouche; J Audouin
Journal:  Virchows Arch       Date:  2007-01-25       Impact factor: 4.064

2.  CD30-positive anaplastic variant diffuse large B cell lymphoma: a rare case presented with cutaneous involvement.

Authors:  Hiroki Asano; Yoichi Imai; Satoshi Ota; Go Yamamoto; Tsuyoshi Takahashi; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-09-14       Impact factor: 2.490

3.  Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.

Authors:  G Z Rassidakis; A H Sarris; M Herling; R J Ford; F Cabanillas; T J McDonnell; L J Medeiros
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 4.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors:  Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

5.  Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins.

Authors:  Makoto Saito; Shinya Tanaka; Akio Mori; Nobuyasu Toyoshima; Tatsuro Irie; Masanobu Morioka
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

6.  Primary splenic anaplastic variant of diffuse large B-cell lymphoma: a case report.

Authors:  Sawsan Ismail; Filip Ali; Hussein Ajamieh; Samir Kanaan; Rana Issa; Ali Daoud; Zuheir Alshehabi
Journal:  J Med Case Rep       Date:  2021-05-06

7.  Transformation of CLL to ALCL: the role of clonality studies in diagnostic molecular haematopathology.

Authors:  Richard Colling; Daniel Royston; Elizabeth Soilleux
Journal:  J Hematop       Date:  2016-08-08       Impact factor: 0.196

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.